Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ito, Soichi ^a,b   Miyashita, Hiroki ^a   Suzuki, Yasuhiro ^a   Kobayashi, Miho ^a   Satomi, Susumu ^b   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; PROTEIN ZO1; UNCLASSIFIED DRUG; VASOHIBIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMATURITY; LEWIS CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; PERICYTE; TUMOR VASCULARIZATION; VASOHIBIN 1 GENE;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CELL CYCLE PROTEINS; CELL LINE; CELLS, CULTURED; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84884194115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073931     Document Type: Article

References (33)

1. Talmadge JE, Fidler IJ, (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70: 5649-5669.
2. Steeg PS, (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904.
3. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
4. Adams RH, Alitalo K, (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8: 464-478.
5. Carmeliet P, Jain RK, (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10: 417-427.
6. Bergers G, Benjamin LE, (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410.
7. Watanabe K, Hasegawa Y, Yamashita H, Shimizu K, Ding Y, et al. (2004) Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest 114: 898-907.
8. Heishi T, Hosaka T, Suzuki Y, Miyashita H, Oike Y, et al. (2010) Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am J Pathol 176: 1950-1958.
9. Kimura H, Miyashita H, Suzuki Y, Kobayashi M, Watanabe K, et al. (2009) Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood 113: 4810-4818.
10. Miyashita H, Watanabe T, Hayashi H, Suzuki Y, Nakamura T, et al. (2012) Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1. PLoS One 7: e46459.
11. Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, et al. (2008) Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. Cancer Sci 99: 914-919.
12. Hosaka T, Kimura H, Heishi T, Suzuki Y, Miyashita H, et al. (2009) Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis. Am J Pathol 175: 430-439.
13. Tamaki K, Moriya T, Sato Y, Ishida T, Maruo Y, et al. (2009) Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci 100: 88-94.
14. Tamaki K, Sasano H, Maruo Y, Takahashi Y, Miyashita M, et al. (2010) Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast. Cancer Sci. 101: 1051-1058.
15. Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, et al. (2011) Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas. Cancer Sci. 102: 446-451.
16. Miyazaki Y, Kosaka T, Mikami S, Kikuchi E, Tanaka N, et al. (2012) The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma. Clin Cancer Res. 18: 4145-53.
17. Wang Q, Tian X, Zhang C, Wang Q, (2012) Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery. Med Oncol. 29: 2727-2736.
18. Shen Z, Kauttu T, Seppänen H, Vainionpää S, Ye Y, et al. (2012) Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs. Med Oncol 29: 2718-2726.
19. Zhao G, Yang Y, Tang Y, Han R, Sun Y, (2012) Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma. Med Oncol 29: 3325-3334.
20. Yazdani S, Miki Y, Tamaki K, Ono K, Iwabuchi E, et al. (2013) Proliferation and maturation of intratumoral blood vessels in non-small cell lung cancer. Hum Pathol [Epub ahead of print].
21. Kanomata N, Sato Y, Miyaji Y, Nagai A, Moriya T, (2013) Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma. J Clin Pathol 66: 613-619.
22. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, et al. (2010) Regulation of tumor angiogenesis by EZH2. Cancer Cell 18: 185-197.
23. Yonenaga Y, Mori A, Onodera H, Yasuda S, Oe H, et al. (2005) Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 69: 159-166.
24. Xian X, Hakansson J, Stahlberg A, Lindblom P, Betsholtz C, et al. (2006) Pericytes limit tumor cell metastasis. J Clin Invest 116: 642-651.
25. Raza A, Franklin MJ, Dudek AZ, (2010) Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 85: 593-598.
26. Cooke VG, LeBleu VS, Keskin D, Khan Z, O'Connell JT, et al. (2012) Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 21: 66-81.
27. Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, et al. (2011) HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19: 31-44.
28. Dejana E, Tournier-Lasserve E, Weinstein BM, (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16: 209-221.
29. Martin TA, Jiang WG, (2009) Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 1788: 872-891.
30. Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, et al. (2005) Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms. J Cutan Pathol 32: 533-536.
31. Sakaguchi T, Suzuki S, Higashi H, Inaba K, Nakamura S, et al. (2008) Expression of tight junction protein claudin-5 in tumor vessels and sinusoidal endothelium in patients with hepatocellular carcinoma. J Surg Res 147: 123-131.
32. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, et al. (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136: 839-851.
33. Carmeliet P, De Smet F, Loges S, Mazzone M, (2009) Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat Rev Clin Oncol 6: 315-326.